Lanzetta, G <br/><br/>
Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.  [electronic resource] 

 -  Anticancer research   
 - 5159-64 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>0250-7005 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents, Alkylating--adverse effects<br/>Brain Neoplasms--drug therapy<br/>Combined Modality Therapy<br/>Dacarbazine--adverse effects<br/>Dose Fractionation, Radiation<br/>Female<br/>Glioblastoma--drug therapy<br/>Humans<br/>Male<br/>Middle Aged<br/>Temozolomide